Press release
July 15, 2026
Pulmonx to Report Second Quarter 2026 Financial Results on July 29, 2026
Pulmonx Corp (LUNG)
REDWOOD CITY, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the second quarter of 2026 after the close of trading on Wednesday,